241 related articles for article (PubMed ID: 10050892)
1. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders.
Dalmau J; Gultekin SH; Voltz R; Hoard R; DesChamps T; Balmaceda C; Batchelor T; Gerstner E; Eichen J; Frennier J; Posner JB; Rosenfeld MR
Brain; 1999 Jan; 122 ( Pt 1)():27-39. PubMed ID: 10050892
[TBL] [Abstract][Full Text] [Related]
2. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.
Voltz R; Gultekin SH; Rosenfeld MR; Gerstner E; Eichen J; Posner JB; Dalmau J
N Engl J Med; 1999 Jun; 340(23):1788-95. PubMed ID: 10362822
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.
Rosenfeld MR; Eichen JG; Wade DF; Posner JB; Dalmau J
Ann Neurol; 2001 Sep; 50(3):339-48. PubMed ID: 11558790
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Dropcho EJ; Barbut D; Chen YT; Rosenblum MK; Old LJ; Posner JB
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2873-7. PubMed ID: 2649898
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.
Ortega Suero G; Sola-Valls N; Escudero D; Saiz A; Graus F
Neurologia (Engl Ed); 2018; 33(1):18-27. PubMed ID: 27460184
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB
Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270
[TBL] [Abstract][Full Text] [Related]
7. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT; Smitt PS; Dalmau J; Posner JB
Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
[TBL] [Abstract][Full Text] [Related]
8. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
[TBL] [Abstract][Full Text] [Related]
10. The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease.
Schüller M; Jenne D; Voltz R
J Neuroimmunol; 2005 Dec; 169(1-2):172-6. PubMed ID: 16214224
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes.
Smith JL; Finley JC; Lennon VA
J Neuroimmunol; 1988 Apr; 18(1):37-48. PubMed ID: 3346369
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
Anderson NE; Rosenblum MK; Posner JB
Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.
Honnorat J; Antoine JC; Derrington E; Aguera M; Belin MF
J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):270-8. PubMed ID: 8795598
[TBL] [Abstract][Full Text] [Related]
14. Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia.
Greenlee JE; Brashear HR; Herndon RM
J Neuropathol Exp Neurol; 1988 Sep; 47(5):561-71. PubMed ID: 3049946
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system.
Moll JW; Henzen-Logmans SC; Splinter TA; van der Burg ME; Vecht CJ
J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):940-3. PubMed ID: 2178180
[TBL] [Abstract][Full Text] [Related]
17. [Autoimmunity and paraneoplastic neurologic syndromes].
Delattre JY; Davila L; Vega F; Poisson M
Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
[TBL] [Abstract][Full Text] [Related]
18. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration.
Fathallah-Shaykh H; Wolf S; Wong E; Posner JB; Furneaux HM
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3451-4. PubMed ID: 2014264
[TBL] [Abstract][Full Text] [Related]
19. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
Mygland A
Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
[TBL] [Abstract][Full Text] [Related]
20. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
